Objective: Acute coronary syndrome (ACS) has become more frequent in the elderly population due to increased life expectancy. The aim of this trial was to determine clinical and laboratory factors related to in-hospital mortality in patients over 80 years of age who presented with ACS.
T he number of very elderly patients presenting with acute coronary syndrome (ACS) is steadily increasing due to increased life expectancy. [1] Patients aged more than 75 years account for more than onethird of those presenting with ACS and constitute more than 50% of in-hospital mortality due to ACS. [2] ACS in the very elderly population is a complex entity, not only because of the greater ischemic risk, but also as a result of more treatment-related complications.
Scientific evidence concerning very elderly patients with ACS is scarce. Most randomized trials have excluded such patients, despite the rate at which this population is growing. Though there are no specific guidelines concerning the very elderly, it is accepted that the standard treatment should not be less effective in this population. [3] Indeed, over the last decade, an almost linear decrease in the rate of mortality after ACS has been reported in all age classes, including the elderly, in association with the increased use of early percutaneous coronary intervention (PCI) and recommended medications. [4] According to the Turkish Statistical Institute, the average life expectancy has increased to 75 years for males and 80 years for females in Turkey.
[5] Data on the clinical characteristics and outcomes of octogenarian ACS patients in Turkey are limited. In previous studies of octogenarians with ACS, in-hospital mortality was determined to be between 15% and 20%. [6, 7] A recent study from Turkey indicated that octogenarians had a 10.6-fold higher mortality risk after ACS compared with younger patients. [7] The aim of this study was to determine clinical and laboratory factors related to in-hospital mortality in patients over 80 years of age presenting with ACS.
METHODS
The records of consecutive patients aged over 80 years and hospitalized in Pamukkale University Hospital (Denizli, Turkey) between August 2014 and October 2017 due to a diagnosis of ACS were screened retrospectively. Pamukkale University hospital is a tertiary center with the capability to perform coronary angiography and PCI 24 hours a day, 7 days a week. Patients with suspected ACS were evaluated by the emergency team and cardiologists until a final diagnosis could be made.
Clinical
and d e m o g r a p h i c characteristics of the patients were recorded on admission. Serum levels of fasting blood glucose, hemoglobin, C-reactive protein, and a lipid panel including low-density lipoprotein cholesterol, highdensity lipoprotein cholesterol, and triglyceride level measurements obtained within the first 24 hours were also documented. Hypertension was defined as previous documentation of a systolic blood pressure of 140 mm Hg and/or a diastolic blood pressure of 90 mm Hg in at least 2 measurements or active use of any antihypertensive agent. Diabetes mellitus was defined as a fasting plasma glucose level over 126 mg/dL, a glucose level over 200 mg/dL, or a glycated hemoglobin level over 6.5% in any measurement, or the active use of an antidiabetic agent.
All of the patients received medications as recommended in the current guidelines. [8, 9] A loading dose of 300 mg acetylsalicylic acid was administered to all of the patients after the diagnosis of ACS. Clopidogrel (300 mg or 600 mg loading dose) or ticagrelor (180 mg loading dose) was also administered according to the preference of the patients' primary physician. Unfractionated heparin or low-molecular-weight heparin was given according to the patient's weight. Statin treatment was also initiated for all of the patients. The decision to perform coronary angiography, and the timing and type of revascularization procedure were determined by patient's cardiology consultant.
In-hospital bleeding events were classified according to the Thrombolysis in Myocardial Infarction (TIMI) bleeding criteria. [10] Major bleeding was defined as any intracranial bleeding or clinically overt signs of hemorrhage associated with a drop in hemoglobin of ≥5 g/dL or a ≥15% absolute decrease in hematocrit. Minor bleeding was defined as clinically overt, resulting in hemoglobin drop of 3 to <5 g/dL or ≥10% decrease in hematocrit or no observed blood loss in case of ≥4 g/dL decrease in the hemoglobin concentration The analyses were conducted using IBM SPSS Statistics for Windows, Version 24.0. (IBM Corp., Armonk, NY, USA). To test the distribution pattern, the Kolmogorov-Smirnov and Shapiro-Wilk tests were used, as well as assessment of skewness and kurtosis. Continuous data that were not distributed normally were presented as median (interquartile range) and categorical variables were described as percentages. Categorical variables were compared with a chisquare test. Yates' correction was used as necessary. Fisher's exact test was used when expected frequencies were less than or equal to 5. Continuous variables were compared using the Mann-Whitney U test. Multivariate, stepwise backward logistic regression analysis was used to detect the independent predictors of mortality. All of the parameters in the univariate analysis with a p value <0.25 and variables that are known risk factors for coronary artery disease were selected in the multivariate model. An exploratory evaluation of additional cut points was performed using receiver operating characteristic curve analysis (ROC). A p value of <0.05 was considered statistically significant.
This study was performed in compliance with the principles outlined in the Declaration of Helsinki and was approved by the local ethics committee.
RESULTS
A total of 171 patients (86 males, 50.3%) with a median age of 83 (4) years were included in the study. The initial diagnosis was unstable angina pectoris in 37 (21.6%), ST-segment elevation myocardial infarction (STEMI) in 45 (26.3%) patients, and non-STEMI in 89 (52%). Coronary angiography was performed in 97 cases (56.7%) and 74 patients (43.3%) were only followed up medically. Among the patients who underwent coronary angiography, 61 patients (62.8%) had 3-vessel disease, 22 patients (22.7%) had 2-vessel disease, and 14 patients (14.4%) had 1-vessel disease. In all, 57 (58.7%) patients underwent PCI, 23 (23.7%) patients underwent coronary artery bypass graft (CABG) surgery, and 17 (17.5%) patients were followed up medically according to the results of coronary angiography. The primary reason for medical follow-up was refusal of coronary angiography by the patient or their relatives (n=61, 82.4%). Other reasons included the presence of kidney problems (n=10, 13.5%), active gastrointestinal bleeding (n=2, 2.7%), or end-stage malignancy (n=1, 1.35%). None of the patients received thrombolytic therapy. Eight patients received a tirofiban infusion after coronary angiography. According to the TIMI bleeding classification, 5 patients (2.9%) had minor bleeding and 11 patients (6.4%) had minimal bleeding. There was a significant difference in the bleeding rate between patients who died and those who survived in-hospital (p=0.083).
During follow-up, 19 of 171 patients (11.1%) died in-hospital. The causes of death were cardiogenic shock (n=6, 31.5%), acute renal failure (n=6, 31.5%), arrhythmia (n=4, 21%), and septic shock (n=3, 15.7%).
The demographic and clinical features of patients according to in-hospital mortality are presented in Table 2 . The patients who died during in-hospital follow-up were less likely to be taking an angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) before admission (10.5% vs 42.1%, p=0.01).
The most common presenting symptom upon arrival at the hospital was chest pain (73.1%). Other presenting symptoms were dyspnea (11.7%), syncope (8.5%), and other non-cardiac symptoms (5%), such as nausea, dizziness, or stomach pain. The duration of time between symptom onset to hospital admission was 22.1 hours (0.5-96 hours). A total of 135 patients (79.9%) had sinus rhythm, 27 patients (16%) had atrial fibrillation, 5 patients (2.9%) had an atrioventricular In ROC analysis, a cut-off value of a GRACE score of 170 could predict in-hospital mortality with a 100% sensitivity, 71% specificity, and 26.9% positive and 100% negative predictivity [area under the curve: 0.960, 95% CI: 0.924-0.996; p<0.001) (Fig. 1) .
DISCUSSION
In this single-center study, we tried to determine factors related to in-hospital mortality in very elderly patients presenting with ACS. Among the clinical factors evaluated, a high GRACE risk score, a low EF on admission (<0.40), and no use of an ACEI/ARB before admission were found to be independent risk factors related to mortality.
The percentage of the population that is very elderly is increasing steadily in developed and developing countries. In Turkey, they represented 8% of the population in 2018.
[5] Advanced age per se is a strong risk factor for increased risk of mortality from myocardial infarction. [11] Additionally, the elderly have more advanced and extensive coronary artery disease. [12] However, clinical experience tells us that uncertainties remain regarding both the diagnosis and the treatment of elderly patients with ACS. When they present with ACS, symptoms in the elderly can be atypical and electrocardiography results can be more difficult to interpret due to the higher incidence of left bundle branch block or other rhythms. [13, 14] Cardiac troponins are more often elevated in the elderly even in the absence of ACS, which could add further to the uncertainty of whether or not the patient has a myocardial infarction.
Age is not only a powerful risk factor for cardiovascular disease but also an independent risk factor for adverse outcomes after cardiovascular events, for Data is presented as median (IQR). *Systolic blood pressure, diastolic pressure, and heart rate of patients at the time of hospital admission. **Mann-Whitney U test ***Fisher's exact test. CK-MB: Creatinine kinase MB; GRACE: Global Registry of Acute Coronary Event.
The GRACE score is a strong, independent predictor of adverse events and mortality in patients with ACS. [21] Vassali et al. [22] reported that for elderly patients presenting with ACS who were referred for PCI within 24 hours of admission, the GRACE score, independent from other risk scores, predicted 30-day mortality. Similarly, we also found that the admission GRACE score was associated with in-hospital mortality.
Current guidelines recommend the use of ACE inhibitors or ARBs in patients with an impaired left ventricle EF (≤40%) or who have experienced heart failure after ACS. [21] However, in our study, use of these drugs before presentation was found to be protective against mortality. However, use of mineralocorticoid receptor antagonists before hospital admission was not found to be related to mortality.
There are some limitations to our study. First, this study had a retrospective, cross-sectional design using single-center data. Due to the retrospective retrieval of the patient data and the small number of patients included, our study results can't be generalized to the whole elderly population. Second, the diagnosis of ACS in the elderly population is challenging; multiple cofactors may affect cardiac enzyme elevation and some patients could be misdiagnosed. Finally, the presence of multiple comorbidities and fragility also affect in-hospital mortality rates in elderly patients.
In conclusion, due to increased life expectancy, physicians will be confronted with an increasing number of elderly and very elderly patients presenting with ACS. Physicians should be aware of clinical factors related to increased mortality in this age group. Although we didn't find that invasive treatment had a significant positive impact on in-hospital mortality, these are generally safe procedures and advanced age should not be a reason to withold potentially life saving procedures and interventions.
complications of cardiovascular procedures and interventions, and for side effects of pharmacotherapy, particularly from antithrombotic therapies. [15] In a trial conducted by Scechter et al., [16] it was demonstrated that ACS patients over 80 had more in-hospital major adverse cardiac events (including re-infarction, post-infarction angina, ischemic stroke, high-degree atrioventricular block, acute renal failure, and major bleeding) and also had a four-to fivefold higher mortality rate than younger patients.
Additionally, the hemodynamic impact of a given infarct size may be more pronounced in the elderly as a result of reduced cardiac reserve. [17] There is also a greater likelihood of comorbid illnesses with advancing age. Not only do these comorbidities obscure the presentation of ACS, they also contribute to poorer outcomes. As we found in our study, the presence of a diabetes is related to mortality in this age group.
We found a statistically significant relationship between reduced EF and in-hospital mortality in the elderly population with ACS. Similar to our results, in another study from Turkey, Atas et al. [6] found that presentation with STEMI, hypotension, and a low left ventricular EF were independent predictors of in-hospital mortality, while hyponatremia, atrial fibrillation, and renal dysfunction were independent predictors of long-term mortality in elderly patients with ACS.
Though elderly patients have more severe coronary disease than younger patients at coronary angiography, they are more likely to be treated medically and they experience more adverse outcomes. [15] A post-hoc analysis of a large randomized trial revealed that the oldest patients with ACS benefited most from an invasive treatment strategy. [18] In this study, 33% (n=57) of the patients underwent PCI and 13.4% (n=23) of patients underwent CABG surgery. However, a recent dedicated randomized clinical trial in the elderly addressing the question of the benefit of an invasive treatment strategy in ACS showed a reduction in mortality only in elderly patients with high cardiac troponins. [19] Whether or not age is a true effect modifier in ACS remains a matter of debate. [20] According to the TIMI bleeding classification, none of our patients had major bleeding during their in-hospital stay. Elderly patients are more prone to bleeding due to their greater risk profile. However, we may not have seen any major bleeding in our study as a result of the small size of the study population.
